Frank Anders Wilson
CIK: 0001462948
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (14 total)
- May 21, 2026ALKS
Alkermes plc.
Exercise(M)Direct6.1K shares- - May 21, 2026ALKS
Alkermes plc.
Tax Payment(F)Direct1.5K shares at avg. $36.95$55K - May 20, 2026ALKS
Alkermes plc.
Award(A)DirectRestricted Stock Unit Award
5.4K shares- - May 20, 2026ALKS
Alkermes plc.
Award(A)DirectNon Qualified Stock Option (Right to Buy)
11.5K shares- - Jan 8, 2026CBT
CABOT CORP
Award(A)Direct2.3K shares- - Jan 2, 2026NOVT
NOVANTA INC
Exercise(M)Direct1.3K shares- - Jan 2, 2026NOVT
NOVANTA INC
Award(A)DirectRestricted Stock Units
1.8K shares- - May 31, 2025ALKS
Alkermes plc.
Exercise(M)Direct8K shares- - May 31, 2025ALKS
Alkermes plc.
Tax Payment(F)Direct1.9K shares at avg. $30.61$59K - May 21, 2025ALKS
Alkermes plc.
Award(A)DirectNon Qualified Stock Option (Right to Buy)
13.5K shares- - May 21, 2025ALKS
Alkermes plc.
Award(A)DirectRestricted Stock Unit Award
6.1K shares- - Jan 10, 2025CBT
CABOT CORP
Award(A)Direct1.8K shares- - Jan 2, 2025NOVT
NOVANTA INC
Award(A)DirectRestricted Stock Units
1.3K shares- - Jan 2, 2025NOVT
NOVANTA INC
Exercise(M)Direct1.2K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| May 21, 2026 |  ALKS Alkermes plc. | Exercise(M) | 6,142 | - | $0 | Direct |
| May 21, 2026 | ALKS Alkermes plc. | Tax Payment(F) | 1,475 | $36.95 | $54,501 | Direct |
| May 20, 2026 | ALKS Alkermes plc. | Award(A) Restricted Stock Unit Award | 5,409 | - | - | Direct |
| May 20, 2026 | ALKS Alkermes plc. | Award(A) Non Qualified Stock Option (Right to Buy) | 11,538 | - | - | Direct |
| Jan 8, 2026 |  CBT CABOT CORP | Award(A) | 2,298 | - | $0 | Direct |
| Jan 2, 2026 |  NOVT NOVANTA INC | Exercise(M) | 1,325 | - | $0 | Direct |
| Jan 2, 2026 | NOVT NOVANTA INC | Award(A) Restricted Stock Units | 1,799 | - | - | Direct |
| May 31, 2025 | ALKS Alkermes plc. | Exercise(M) | 8,013 | - | - | Direct |
| May 31, 2025 | ALKS Alkermes plc. | Tax Payment(F) | 1,924 | $30.61 | $58,894 | Direct |
| May 21, 2025 | ALKS Alkermes plc. | Award(A) Non Qualified Stock Option (Right to Buy) | 13,474 | - | - | Direct |
| May 21, 2025 | ALKS Alkermes plc. | Award(A) Restricted Stock Unit Award | 6,142 | - | - | Direct |
| Jan 10, 2025 | CBT CABOT CORP | Award(A) | 1,788 | - | $0 | Direct |
| Jan 2, 2025 | NOVT NOVANTA INC | Award(A) Restricted Stock Units | 1,325 | - | - | Direct |
| Jan 2, 2025 | NOVT NOVANTA INC | Exercise(M) | 1,217 | - | $0 | Direct |
1-14 of 14 transactions
About Wilson Frank Anders
Wilson Frank Anders (SEC CIK 0001462948) files insider reports with the SEC as Director of Alkermes plc. (ALKS), Director of CABOT CORP (CBT) and Director of NOVANTA INC (NOVT).
Signal8 holds 7 ownership filings by Wilson Frank Anders, all Form 4s, filed between Jan 6, 2025 and May 22, 2026. Those filings report 14 transactions, from Jan 2, 2025 to May 21, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Wilson Frank Anders's filings is in BEDFORD, MA.
Recent filings by Wilson Frank Anders
- May 21, 2026: Option exercise of ALKS shares (Form 4, code M).
- May 21, 2026: Tax withholding of ALKS shares (Form 4, code F).
- May 20, 2026: Grants or awards of ALKS derivative securities (2 lines, Form 4, code A).
- Jan 8, 2026: Grant or award of CBT shares (Form 4, code A).
- Jan 2, 2026: Option exercise of NOVT shares (Form 4, code M).
Other insiders filing for Alkermes plc. (ALKS)
- Gaffin David Joseph, EVP, CLO, Alkermes, Inc.
- Reed Joshua, SVP, Chief Financial Officer
- Whitaker Anne Clem, Director
- Hopkinson Craig C., EVP R&D, Chief Medical Officer
- Nichols Christian Todd, SVP, Chief Commercial Officer
- Jackson Blair Curtis, President & CEO, Alkermes plc